Adult Cancer Incidence
According to the American Cancer Society, cancer affects one in three Americans in their lifetime. We aimed to trend how cancer screenings and diagnoses have changed over time, and how they were influenced by the pandemic. Our data tracker shows the quarterly rates of overall and advanced cancer diagnoses over the past five years to understand overall trends in cancer, including breakdowns for specific cancer types.
Trends Over Time
Prostate cancer is the second most common cancer diagnosed in men in the U.S. after skin cancer. While prostate cancer screening is not universally recommended, screening remains an important tool for patients who might be at high risk. While the incidence of prostate cancer has declined over the last few decades, the pace of that decline has recently slowed.
Prostate Cancer Cases
Q2 2026
Quarterly rates of new cancer diagnoses per 100,000 patients.
Advanced Prostate Cancer Cases
Q2 2026
Quarterly rates of new advanced cancer diagnoses per 100,000 patients.
Prostate Cancer Screenings
Q2 2026
Quarterly rates of screenings per 100,000 patients.
Metric Definitions
- Numerator (Male)
- The number of distinct male patients identified in that quarter having the event of interest (Cancer Diagnosis, Cancer Screening, Pre-Cancer Diagnosis, or Advanced Cancer). Patients are excluded if they have previously had a Cancer Diagnosis of that type. Departments must contribute data for the entire study period to be included.
- Denominator (Male)
- The number of distinct male patients identified in that quarter having an in-person encounter. Departments must contribute data for the entire study period to be included.
- Prostate Cancer Diagnosis
- A diagnosis with ICD-10-CM code of C61.
- Advanced Cancer
- Advanced cancer cases are defined as either a Metastatic Diagnosis within 3 months after an initial Cancer Diagnosis, or the cancer classified as Stage 4 within 3 months after an initial Cancer Diagnosis of the same type.
- Prostate Cancer Screening
- A procedure with CPT code of 84152, 84153 or a procedure with HCPCS code of G0103 or a lab with LOINC code of 2857-1, 33667-7, 83112-3, 35741-8, 19195-7.
- Metastatic Diagnosis
- A diagnosis with ICD-10-CM code of C7B*, C78*, C79*, C77*.
Related Articles
ExpandProstate Cancer Screening and Diagnosis Rates Up for 55–84-Year-Old Men
Prostate cancer screening rates have increased for men aged 45 and older since 2021, with the most pronounced increase seen in men aged 55–64 rising by nearly 50% from Q1 2021 to Q4 2025.
